相关实验视频

Updated: May 17, 2025

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

通过诱导式抑制ESCRT-III进行HIV-1芽控制的协议

Haiyan Wang¹, Winfried Weissenhorn¹, Cécile Boscheron¹

¹University Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

|May 15, 2025

概括

这项研究引入了一种新的方法,可以暂时阻止HIV-1病毒样粒子 (VLP) 的释放. 通过使用由药物激活的工程ESCRT-III蛋白质,研究人员可以控制用于科学研究的VLP生产.

科学领域:

病毒学病毒学
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

人类免疫缺陷病毒1型 (HIV-1) 的组装和释放是复杂的过程.
传输所需的内体组分复合体 (ESCRT) 机器在病毒芽中发挥着至关重要的作用.
控制病毒释放对于研究病毒复制和开发抗病毒策略至关重要.

研究的目的:

开发一种时间抑制HIV-1病毒样粒子 (VLP) 释放的协议.
创建融合蛋白质,将ESCRT-III组件与可诱导抑制的蛋白酶结合起来.
建立一种用于活细胞成像和量化VLP释放动态的方法.

主要方法:

和CHMP-NS3-绿色等离子体的同时传染到HEK293或HeLa细胞中.
使用型肝炎病毒NS3蛋白酶与ESCRT-III蛋白质 (CHMP-NS3-绿色) 融合.
在添加NS3抑制剂Glecaprevir后,诱导性主导负抑制VLP释放.
蛋白质表达的分析,VLP量化通过免疫阻塞和活细胞成像.

主要成果:

功能ESCRT-III-NS3蛋白酶融合蛋白的成功表达.
在 Glecaprevir 治疗后对 HIV-1 VLP 释放的时间抑制的证明.
使用活细胞成像,量化VLP释放和可视化抑制动态.

结论:

开发的协议允许精确的时间控制HIV-1 VLP释放.
该系统为研究HIV-1复制的后期阶段提供了有价值的工具.
诱导性抑制策略为未来的抗病毒研究提供了潜力.

关键词:

细胞生物学细胞生物学微生物学的微生物.显微镜显微镜是指使用显微镜.

更多相关视频

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity

Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity

Published on: June 14, 2024

相关概念视频

Intralumenal Vesicles and Multivesicular Bodies

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...

Pinching-off of Coated Vesicles

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...